Etiology of acute lower respiratory tract infections in Gambian children: II. Acute lower respiratory tract infection in children ages one to nine years presenting at the hospital.

PubWeight™: 1.57‹?› | Rank: Top 4%

🔗 View Article (PMID 2003054)

Published in Pediatr Infect Dis J on January 01, 1991

Authors

I M Forgie1, K P O'Neill, N Lloyd-Evans, M Leinonen, H Campbell, H C Whittle, B M Greenwood

Author Affiliations

1: Medical Research Council Laboratories, Fajara, Banjul, The Gambia.

Articles citing this

Epidemiology and etiology of childhood pneumonia. Bull World Health Organ (2008) 9.17

Viral etiology of severe pneumonia among Kenyan infants and children. JAMA (2010) 4.41

The epidemiology of pneumococcal infection in children in the developing world. Philos Trans R Soc Lond B Biol Sci (1999) 2.17

Pneumonia research to reduce childhood mortality in the developing world. J Clin Invest (2008) 2.01

Molecular epidemiology of pneumococci obtained from Gambian children aged 2-29 months with invasive pneumococcal disease during a trial of a 9-valent pneumococcal conjugate vaccine. BMC Infect Dis (2008) 1.43

What are the implications for childhood pneumonia of successfully introducing Hib and pneumococcal vaccines in developing countries? PLoS Med (2008) 1.37

Bacterial pneumonia and pandemic influenza planning. Emerg Infect Dis (2008) 1.30

Role of pneumococcal antigen in the diagnosis of pneumococcal pneumonia. Thorax (1992) 1.22

Economic evaluation of pneumococcal conjugate vaccination in The Gambia. BMC Infect Dis (2010) 1.06

Detection of Haemophilus influenzae and Streptococcus pneumoniae DNA in blood culture by a single PCR assay. J Clin Microbiol (1996) 1.04

Capsular serotype and antibiotic resistance of Streptococcus pneumoniae isolates in two Chilean cities. Clin Diagn Lab Immunol (1998) 0.92

Acute respiratory infection: a global challenge. Arch Dis Child (1995) 0.91

Pneumococcal serology in children's respiratory infections. Eur J Clin Microbiol Infect Dis (2007) 0.87

An evaluation of the emerging vaccines and immunotherapy against staphylococcal pneumonia in children. BMC Public Health (2011) 0.83

Outcome risk factors during respiratory infections in a paediatric ward in Antananarivo, Madagascar 2010-2012. PLoS One (2013) 0.82

Severe lower respiratory tract infection in early infancy and pneumonia hospitalizations among children, Kenya. Emerg Infect Dis (2013) 0.80

Role of human metapneumovirus, influenza A virus and respiratory syncytial virus in causing WHO-defined severe pneumonia in children in a developing country. PLoS One (2013) 0.78

Parenteral-oral switch in the management of paediatric pneumonia. Drugs (1994) 0.77

Oropharyngeal production of pneumococcal capsular antigen and the potential for contamination of expectorated sputum samples in pneumococcal pneumonia. Epidemiol Infect (1993) 0.75

Enhanced Diagnosis of Pneumococcal Bacteremia Using Antigen- and Molecular-Based Tools on Blood Specimens in Mali and Thailand: A Prospective Surveillance Study. Am J Trop Med Hyg (2015) 0.75

Respiratory syncytial virus genotypes circulating in urban Ghana: February to November 2006. Pan Afr Med J (2014) 0.75

Immunopathogenesis of Chlamydia pneumoniae Infections in children. Infect Dis Obstet Gynecol (1996) 0.75

Articles by these authors

Common west African HLA antigens are associated with protection from severe malaria. Nature (1991) 9.43

Averting a malaria disaster. Lancet (1999) 9.40

Mortality and morbidity from malaria in Gambian children after introduction of an impregnated bednet programme. Lancet (1995) 8.71

Puerperal thromboembolism and suppression of lactation. Lancet (1967) 8.22

Efficacy of nine-valent pneumococcal conjugate vaccine against pneumonia and invasive pneumococcal disease in The Gambia: randomised, double-blind, placebo-controlled trial. Lancet (2005) 7.99

Serological evidence of an association of a novel Chlamydia, TWAR, with chronic coronary heart disease and acute myocardial infarction. Lancet (1988) 7.59

TNF concentration in fatal cerebral, non-fatal cerebral, and uncomplicated Plasmodium falciparum malaria. Lancet (1990) 6.32

Variations in the NRAMP1 gene and susceptibility to tuberculosis in West Africans. N Engl J Med (1998) 6.14

Counter-current immunoelectrophoresis in the diagnosis of meningococcal infections. Lancet (1971) 6.05

Chronic Chlamydia pneumoniae infection as a risk factor for coronary heart disease in the Helsinki Heart Study. Ann Intern Med (1992) 5.65

Antigenic similarities between brain components and bacteria causing meningitis. Implications for vaccine development and pathogenesis. Lancet (1983) 5.63

Randomised trial of 23-valent pneumococcal capsular polysaccharide vaccine in prevention of pneumonia in middle-aged and elderly people. Swedish Pneumococcal Vaccination Study Group. Lancet (1998) 5.15

Efficacy of RTS,S/AS02 malaria vaccine against Plasmodium falciparum infection in semi-immune adult men in The Gambia: a randomised trial. Lancet (2001) 5.01

Etiology of community-acquired pneumonia in 254 hospitalized children. Pediatr Infect Dis J (2000) 4.87

Bronchitis in two integrated steel works. I. Ventilatory capacity, age, and physique of non-bronchitic men. Br J Prev Soc Med (1968) 4.75

Antibodies to blood stage antigens of Plasmodium falciparum in rural Gambians and their relation to protection against infection. Trans R Soc Trop Med Hyg (1990) 4.70

Human cerebral malaria: association with erythrocyte rosetting and lack of anti-rosetting antibodies. Lancet (1990) 4.58

Variation in the TNF-alpha promoter region associated with susceptibility to cerebral malaria. Nature (1994) 4.37

Double-blind randomised controlled trial of folate treatment before conception to prevent recurrence of neural-tube defects. Br Med J (Clin Res Ed) (1981) 4.12

Natural family planning in the 1990s. Lancet (1995) 3.97

Molecular analysis of the association of HLA-B53 and resistance to severe malaria. Nature (1992) 3.93

Prospective study of the incidence, aetiology and outcome of adult lower respiratory tract illness in the community. Thorax (2001) 3.72

Rapid bacteriological diagnosis of pyogenic meningitis by latex agglutination. Lancet (1974) 3.64

Overlap in the clinical features of pneumonia and malaria in African children. Trans R Soc Trop Med Hyg (1994) 3.58

Association between an MHC class II allele and clearance of hepatitis B virus in the Gambia. N Engl J Med (1995) 3.54

Obstetric practice and outcome of pregnancy in Cardiff residents 1965-73. Br Med J (1976) 3.54

Clinical immunity to Plasmodium falciparum malaria is associated with serum antibodies to the 19-kDa C-terminal fragment of the merozoite surface antigen, PfMSP-1. J Infect Dis (1996) 3.49

Emphysema in coal workers' pneumoconiosis. Br Med J (1970) 3.48

Association of malaria parasite population structure, HLA, and immunological antagonism. Science (1998) 3.40

Respiratory syncytial virus infection in tropical and developing countries. Trop Med Int Health (1998) 3.38

Study of community acquired pneumonia aetiology (SCAPA) in adults admitted to hospital: implications for management guidelines. Thorax (2001) 3.38

Environmental epidemiology. IV. Chronic respiratory disease in an industrial town: a nine-year follow-up study. Preliminary report. Am J Public Health Nations Health (1968) 3.33

Poisoning by bites of the saw-scaled or carpet viper (Echis carinatus) in Nigeria. Q J Med (1977) 3.27

Viruses and bacteria in the etiology of the common cold. J Clin Microbiol (1998) 3.24

Autoimmune disease and parasitic infections in Nigerians. Lancet (1968) 3.22

The magnitude of mortality from acute respiratory infections in children under 5 years in developing countries. World Health Stat Q (1992) 3.14

Naturally acquired cellular and humoral immune responses to the major merozoite surface antigen (PfMSP1) of Plasmodium falciparum are associated with reduced malaria morbidity. Parasite Immunol (1992) 3.12

Immunosuppression in children with malaria. Lancet (1972) 3.11

A principal target of human immunity to malaria identified by molecular population genetic and immunological analyses. Nat Med (2000) 3.06

High recombination rate in natural populations of Plasmodium falciparum. Proc Natl Acad Sci U S A (1999) 3.03

Evaluation of an algorithm for the integrated management of childhood illness in an area with seasonal malaria in the Gambia. Bull World Health Organ (1997) 3.00

A polymorphism that affects OCT-1 binding to the TNF promoter region is associated with severe malaria. Nat Genet (1999) 2.83

Possible role of a B-cell mitogen in hypergammaglobulinaemia in malaria and trypanosomiasis. Lancet (1974) 2.83

Reduction of oropharyngeal carriage of Haemophilus influenzae type b (Hib) in children immunized with an Hib conjugate vaccine. J Infect Dis (1991) 2.83

Tuberculosis and chronic hepatitis B virus infection in Africans and variation in the vitamin D receptor gene. J Infect Dis (1999) 2.79

Corneal ulceration following measles in Nigerian children. Br J Ophthalmol (1979) 2.79

TERC polymorphisms are associated both with susceptibility to colorectal cancer and with longer telomeres. Gut (2011) 2.75

Gastric emptying in health and in gastroduodenal disease. Gastroenterology (1968) 2.75

Pneumococcal antigen in lobar pneumonia. J Clin Pathol (1975) 2.75

Randomised controlled trial of single-dose azithromycin in treatment of trachoma. Lancet (1993) 2.74

The etiology of pneumonia in malnourished and well-nourished Gambian children. Pediatr Infect Dis J (1994) 2.73

Chlamydia pneumoniae-specific circulating immune complexes in patients with chronic coronary heart disease. Circulation (1993) 2.70

Carriage of pneumococci after pneumococcal vaccination. Lancet (1996) 2.69

Diagnosis of bacteremic pneumococcal pneumonia by amplification of pneumolysin gene fragment in serum. J Infect Dis (1995) 2.62

Placental malaria. I. Pathological classification. Histopathology (1993) 2.62

Allergic complications of meningococcal disease. II. Immunological investigations. Br Med J (1973) 2.61

Trend analysis of socioeconomic differentials in deaths from injury in childhood in Scotland, 1981-95. BMJ (1999) 2.59

Immunosuppression in murine malaria. I. General characteristics. Clin Exp Immunol (1971) 2.56

The safety of the combination artesunate and pyrimethamine-sulfadoxine given during pregnancy. Trans R Soc Trop Med Hyg (2001) 2.54

Dextran 70 in prophylaxis of thromboembolic disease after surgery: a clinically oriented randomized double-blind trial. Br Med J (1975) 2.51

Evaluation of a computerized field data collection system for health surveys. Bull World Health Organ (1991) 2.51

Assessment of clinical criteria for identification of severe acute lower respiratory tract infections in children. Lancet (1989) 2.51

Screening for people with a family history of colorectal cancer. BMJ (1997) 2.50

Development and technical basis of simplified guidelines for emergency triage assessment and treatment in developing countries. WHO Integrated Management of Childhood Illness (IMCI) Referral Care Project. Arch Dis Child (1999) 2.49

Genetic susceptibility to tuberculosis in Africans: a genome-wide scan. Proc Natl Acad Sci U S A (2000) 2.44

Deaths in infancy and early childhood in a well-vaccinated, rural, West African population. Ann Trop Paediatr (1987) 2.42

Failure of cytotoxic drugs to suppress immune responses of patients with rheumatoid arthritis. Ann Rheum Dis (1970) 2.42

IgG3 antibodies to Plasmodium falciparum merozoite surface protein 2 (MSP2): increasing prevalence with age and association with clinical immunity to malaria. Am J Trop Med Hyg (1998) 2.41

Tumour necrosis factor production in Falciparum malaria and its association with schizont rupture. Clin Exp Immunol (1989) 2.41

Protective efficacy of monoclonal antibodies to class 1 and class 3 outer membrane proteins of Neisseria meningitidis B:15:P1.16 in infant rat infection model: new prospects for vaccine development. Microb Pathog (1987) 2.40

The limitations of verbal autopsy in a malaria-endemic region. Ann Trop Paediatr (1994) 2.40

Permethrin-treated bed nets (mosquito nets) prevent malaria in Gambian children. Trans R Soc Trop Med Hyg (1988) 2.40

National study of microphthalmia, anophthalmia, and coloboma (MAC) in Scotland: investigation of genetic aetiology. J Med Genet (2002) 2.39

Treponemal infection and the outcome of pregnancy in a rural area of The Gambia, west Africa. J Infect Dis (1992) 2.39

Impairment of the immune response to vaccination after acute malaria. Lancet (1978) 2.39

Ankylosing spondylitis in West Africans--evidence for a non-HLA-B27 protective effect. Ann Rheum Dis (1997) 2.33

Comparison of the effects of dexamphetamine and 1-benzylpiperazine in former addicts. Eur J Clin Pharmacol (1973) 2.31

Pulmonary disability in coal workers' pneumoconiosis. Br Med J (1972) 2.29

Increased factor IX levels in puerperium during administration of diethylstilboestrol. Br Med J (1968) 2.29

Pallor as a clinical sign of severe anaemia in children: an investigation in the Gambia. Bull World Health Organ (1997) 2.28

Complement and meningococcal infection. Br Med J (1976) 2.28

Evidence for a malaria mitogen in human malaria. Nature (1975) 2.25

Prevention of pneumococcal disease by vaccination: does serotype replacement matter? Lancet (2000) 2.24

Plasmodium falciparum malaria and Salmonella infections in Gambian children. J Infect Dis (1987) 2.23

The genus-specific antigen of Chlamydia: resemblance to the lipopolysaccharide of enteric bacteria. Science (1983) 2.22

Allertic complications of meningococcal disease. I. Clinical aspects. Br Med J (1973) 2.20

Comparative evaluation of potential components for group B meningococcal vaccine by passive protection in the infant rat and in vitro bactericidal assay. Vaccine (1989) 2.20

Do bedbugs transmit hepatitis B? Lancet (1994) 2.17

The influence of age on the development of the hepatitis B carrier state. Proc Biol Sci (1993) 2.12

Aetiology of community-acquired pneumonia in children treated in hospital. Eur J Pediatr (1993) 2.10

Changes in the pattern of infant and childhood mortality in upper river division, The Gambia, from 1989 to 1993. Trop Med Int Health (1997) 2.09